期刊
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
卷 60, 期 1, 页码 117-120出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2007.07.020
关键词
Aspergillus; galactomannan; piperacillin
We evaluated the impact of piperacillin/tazobactam (PT) therapy on galactomannan enzyme immunoassay (GEI) testing (Platelia(TM); Bio-Rad, Mames La Coquette, France). Galactomannan contents of PT batches were highly variable. We found that false-positive GEI results can be avoided by performance of blood sampling before PT administration and by using separate sites for blood sampling and for administration of antibiotics. (c) 2008 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据